Summary
PEOPLE with advanced liver cancer will be denied new drug Nexavar (also called sorafenib) on the NHS under draft guidance published today.
The National Institute for Health and Clinical Excellence said the price being charged by pharmaceutical firm Bayer for the medicine was "simply too high".See the full content of this document
Extract
Cost Too High for New Drug ; Worldtoday
Cancer chariti...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United Kingdom
Explore vLex
For Professionals
For Partners
Company
Other documents:
Ooh Er Matron. No! Exclusive the Tories at Blackpool 2007 Same Old Tories 2 | Your Money Pounds Notes Loan Hit or Myth | Football: Celtic Charity Fund | Pound Notes: Have a Stress-Free Christmas | Ohlsson Plays with Authority -- Emperor Showcases Iris Extraordinary Leaders and Musicians | Forum: On the Republican Convention and Candidate Bush | Coxs Jenkins Faison Join Century Club in Varsity Wins | Police Headlines
